Northstar Neuroscience is pioneering the development of cortical stimulation therapies. We are working with healthcare partners to develop clinical applications from the science of neurostimulation. Our solutions are tuned to the individual needs of patients – offering greater hope for the renewal and recovery from neurologic injury, disorder or disease – enabling them to regain their quality of life. The following pages are designed to inform you about our clinical research studies nationwide. Please reference the table below for a general status update of Northstar’s clinical research studies.

Please note: All clinical trials have potential benefits and risks. Any prospective participant must sign an informed consent document in which these risks and benefits are outlined and must be discussed with the physician/institution participating in the clinical research. Once the informed consent is signed the patient may be enrolled in the clinical trial. All information collected about patients is subject to protection under a Federal law known as “HIPAA.” More information about informed consent and the protection of the patient’s personal information is provided to prospective clinical trial participants when they inquire about being involved in the clinical trial.